Global Health Valuation
| MEDANTA Stock | 1,249 18.45 1.50% |
At this time, the firm appears to be overvalued. Global Health Limited retains a regular Real Value of USD999.74 per share. The prevalent price of the firm is USD1249.1. Our model calculates the value of Global Health Limited from evaluating the firm fundamentals such as Current Valuation of 327.33 B, return on equity of 0.18, and Return On Asset of 0.093 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 10.5217 | Enterprise Value 327.3 B | Enterprise Value Ebitda 35.8153 | Price Sales 9.401 | Trailing PE 66.3356 |
Overvalued
Today
Please note that Global Health's price fluctuation is very steady at this time. Calculation of the real value of Global Health Limited is based on 3 months time horizon. Increasing Global Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Global Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Global Stock. However, Global Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1249.1 | Real 999.74 | Hype 1244.8 | Naive 1290.26 |
The real value of Global Stock, also known as its intrinsic value, is the underlying worth of Global Health Limited Company, which is reflected in its stock price. It is based on Global Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Global Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Global Health Limited helps investors to forecast how Global stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Global Health more accurately as focusing exclusively on Global Health's fundamentals will not take into account other important factors: Global Health Cash |
|
Global Health Total Value Analysis
Global Health Limited is now estimated to have takeover price of 327.33 B with market capitalization of 335.59 B, debt of 8.02 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Global Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
327.33 B | 335.59 B | 8.02 B |
Global Health Investor Information
About 68.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 18.83. Global Health Limited had not issued any dividends in recent years. Global Health Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 3.9 B | 7 B |
|
| |||||
| Operating Income | 14.1 B | 13.5 B |
|
|
Global Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Global Health has an asset utilization ratio of 76.09 percent. This suggests that the Company is making USD0.76 for each dollar of assets. An increasing asset utilization means that Global Health Limited is more efficient with each dollar of assets it utilizes for everyday operations.Global Health Ownership Allocation
Global Health Limited has a total of 268.59 Million outstanding shares. Global Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.01 (percent) of Global Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Global Health Profitability Analysis
The company reported the revenue of 32.75 B. Net Income was 4.78 B with profit before overhead, payroll, taxes, and interest of 18.37 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Global Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Global Health and how it compares across the competition.
About Global Health Valuation
The stock valuation mechanism determines Global Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Global Health. We calculate exposure to Global Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Global Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 19.7 B | 13 B |
Global Health Quarterly Retained Earnings |
|
Complementary Tools for Global Stock analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |